What Is Celiac Disease?
WEDNESDAY, June 14, 2023 (HealthDay News) — Celiac disease is a chronic disease that can’t be cured, but treatment can help with symptoms.This guide will break down what you need to know about celiac disease, including its causes and symptoms, along …
Learn MoreTraveler’s Diarrhea: Symptoms & How to Get Relief
WEDNESDAY, June 14, 2023 (HealthDay News) — A bout of traveler’s diarrhea can really put a damper on your vacation.Here, experts break down what traveler’s diarrhea is, including its causes, symptoms and treatment, so you can get back to enjoying you…
Learn MoreBreast Density Varies in Racial/Ethnic Groups After BMI Adjustment
WEDNESDAY, June 14, 2023 (HealthDay News) — After adjustment for body mass index (BMI), clinically important differences in the prevalence of dense breasts persist across racial/ethnic groups, according to a study published online June 7 in Cancer Ep…
Learn MoreMifepristone Efficacious for Adenomyosis
WEDNESDAY, June 14, 2023 (HealthDay News) — For patients with adenomyosis, mifepristone is efficacious and has acceptable tolerability, according to a study published online June 12 in JAMA Network Open.Xuan Che, Ph.D., from Zhejiang University in Ha…
Learn MoreOseltamivir Not Linked to Reduced Risk for Flu Hospitalization
WEDNESDAY, June 14, 2023 (HealthDay News) — For outpatients with influenza infection, oseltamivir is not associated with a reduced risk for hospitalization, according to a review published online June 12 in JAMA Internal Medicine.Ryan Hanula, from th…
Learn MoreAthlete Awareness of Sudden Cardiac Arrest Low
WEDNESDAY, June 14, 2023 (HealthDay News) — Few athletes can identify sudden cardiac arrest (SCA) or provide cardiopulmonary resuscitation (CPR) to a fallen athlete, according to research presented at the American College of Cardiology annual Care of…
Learn MoreRituximab Not Noninferior to Ocrelizumab for Relapsing-Remitting MS
WEDNESDAY, June 14, 2023 (HealthDay News) — For patients with relapsing-remitting multiple sclerosis (MS), rituximab is not noninferior to ocrelizumab, according to a study published online June 12 in JAMA Neurology.Izanne Roos, M.B.Ch.B., Ph.D., fro…
Learn MoreWhat Factors Keep Your Dog Healthier Longer? Major Study Has Answers
WEDNESDAY, June 14, 2023 (HealthDay News) — Fido really needs a friend.That’s the main takeaway from a new survey that included more than 21,400 dogs and their owners, and showed that pups who have companions (whether furry or human) live healthier, …
Learn MoreAlectinib Exposure Lower With Low-Fat Yogurt Intake
WEDNESDAY, June 14, 2023 (HealthDay News) — For patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer, alectinib exposure is lower when taken with low-fat yogurt, according to a study published in the June issue of the…
Learn MoreAdolescent Residential Addiction Facilities Largely Do Not Provide Buprenorphine
WEDNESDAY, June 14, 2023 (HealthDay News) — Only one in four U.S. facilities offer buprenorphine for adolescent residential addiction treatment, according to a research letter published in the June 13 issue of the Journal of the American Medical Asso…
Learn More